287 related articles for article (PubMed ID: 16886104)
21. [Comparison of clinicopathologic parameters and prognosis of gastric carcinoma between different phases].
Cai SR; Chen CQ; Ma JP; Chen JH; Song W; He YL; Zhan WH
Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1264-8. PubMed ID: 19595182
[TBL] [Abstract][Full Text] [Related]
22. [Effectiveness of continuous hyperthermic peritoneal perfusion for the peritoneal dissemination of gastric cancer].
Akiyama H; Kunisaki C; Nomura M; Matsuda G; Otsuka Y; Ono H; Shimada H
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2168-73. PubMed ID: 12484029
[TBL] [Abstract][Full Text] [Related]
23. Surgical resection with hyperthermic intraperitoneal chemotherapy for gastric cancer patients with peritoneal dissemination.
Li C; Yan M; Chen J; Xiang M; Zhu ZG; Yin HR; Lin YZ
J Surg Oncol; 2010 Oct; 102(5):361-5. PubMed ID: 20872942
[TBL] [Abstract][Full Text] [Related]
24. Long-term results and prognostic factors of gastric cancer patients with only positive peritoneal lavage cytology.
Oh CA; Bae JM; Oh SJ; Choi MG; Noh JH; Sohn TS; Kim S
J Surg Oncol; 2012 Mar; 105(4):393-9. PubMed ID: 21898416
[TBL] [Abstract][Full Text] [Related]
25. Distal pancreatectomy--does it have a role for pancreatic body and tail cancer.
Kayahara M; Nagakawa T; Ueno K; Ohta T; Kitagawa H; Arakawa H; Yagi H; Tajima H; Miwa K
Hepatogastroenterology; 1998; 45(21):827-32. PubMed ID: 9684142
[TBL] [Abstract][Full Text] [Related]
26. Lower survival rate for patients with carcinoma of the stomach of Borrmann type IV after gastric resection.
Maehara Y; Moriguchi S; Orita H; Kakeji Y; Haraguchi M; Korenaga D; Sugimachi K
Surg Gynecol Obstet; 1992 Jul; 175(1):13-6. PubMed ID: 1621194
[TBL] [Abstract][Full Text] [Related]
27. [Prognostic analysis of surgical resection for patients with liver metastases from gastric cancer].
Wang HY; Li M; Gu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Jan; 8(1):11-3. PubMed ID: 16148988
[TBL] [Abstract][Full Text] [Related]
28. Outcome of radical surgery for stage IV gallbladder carcinoma.
Chijiiwa K; Kai M; Nagano M; Hiyoshi M; Ohuchida J; Kondo K
J Hepatobiliary Pancreat Surg; 2007; 14(4):345-50. PubMed ID: 17653631
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic strategy for patients with pN0 gastric carcinoma.
Kunisaki C; Shimada H; Nomura M; Matsuda G; Otsuka Y; Ono H; Akiyama H
J Surg Oncol; 2006 Sep; 94(3):212-9. PubMed ID: 16900514
[TBL] [Abstract][Full Text] [Related]
30. The implication of N-acetylglucosaminyltransferase V expression in gastric cancer.
Tian H; Miyoshi E; Kawaguchi N; Shaker M; Ito Y; Taniguchi N; Tsujimoto M; Matsuura N
Pathobiology; 2008; 75(5):288-94. PubMed ID: 18931531
[TBL] [Abstract][Full Text] [Related]
31. Advanced gastric carcinoma with signet ring cell histology.
Li C; Kim S; Lai JF; Hyung WJ; Choi WH; Choi SH; Noh SH
Oncology; 2007; 72(1-2):64-8. PubMed ID: 18004078
[TBL] [Abstract][Full Text] [Related]
32. Impact of tumor infiltration pattern into the surrounding tissue on prognosis of the subserosal gastric cancer (pT2b).
Song KY; Hur H; Jung CK; Jung ES; Kim SN; Jeon HM; Park CH
Eur J Surg Oncol; 2010 Jun; 36(6):563-7. PubMed ID: 20462730
[TBL] [Abstract][Full Text] [Related]
33. Intraoperative radiotherapy for pancreatic carcinoma with hepatic or peritoneal metastases.
Nakao A; Harada A; Nonami T; Kaneko T; Takeda S; Kurokawa T; Ishigaki T; Takagi H
Hepatogastroenterology; 1997; 44(17):1469-71. PubMed ID: 9356874
[TBL] [Abstract][Full Text] [Related]
34. Outcome in relation to numbers of nodes harvested in lymph node-positive gastric cancer.
Deng JY; Liang H; Sun D; Pan Y; Zhang RP; Wang BG; Zhan HJ
Eur J Surg Oncol; 2009 Aug; 35(8):814-9. PubMed ID: 19111430
[TBL] [Abstract][Full Text] [Related]
35. Borrmann's macroscopic criteria and p-Smad2 expression are useful predictive prognostic markers for cytology-positive gastric cancer patients without overt peritoneal metastasis.
Noda S; Yashiro M; Toyokawa T; Morimoto J; Shinto O; Muguruma K; Sawada T; Hirakawa K
Ann Surg Oncol; 2011 Dec; 18(13):3718-25. PubMed ID: 21573834
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors in adenocarcinoma in the upper one-third of the stomach.
Maehara Y; Moriguchi S; Kakeji Y; Orita H; Haraguchi M; Korenaga D; Sugimachi K
Surg Gynecol Obstet; 1991 Sep; 173(3):223-6. PubMed ID: 1925884
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of peritoneal cytology and the combination of peritoneal cytology and peritoneal dissemination in colorectal cancer.
Nishikawa T; Watanabe T; Sunami E; Tsuno NH; Kitayama J; Nagawa H
Dis Colon Rectum; 2009 Dec; 52(12):2016-21. PubMed ID: 19934924
[TBL] [Abstract][Full Text] [Related]
38. Prognostic re-evaluation of peritoneal lavage cytology in Japanese patients with gastric carcinoma.
Yamamoto M; Matsuyama A; Kameyama T; Okamoto M; Okazaki J; Utsunomiya T; Tsutsui S; Fujiwara M; Ishida T
Hepatogastroenterology; 2009; 56(89):261-5. PubMed ID: 19453071
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathology and prognosis of mucinous gastric carcinoma.
Hidaka S; Tanaka K; Takeshita H; Sumida Y; Fukuoka H; Abo T; Yano H; Nanashima A; Sawai T; Yasutake T; Nagayasu T
Hepatogastroenterology; 2008; 55(82-83):791-4. PubMed ID: 18613456
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of PCR-based identification of isolated tumour cells in the peritoneal lavage fluid of gastric cancer patients who underwent a curative R0 resection.
Katsuragi K; Yashiro M; Sawada T; Osaka H; Ohira M; Hirakawa K
Br J Cancer; 2007 Aug; 97(4):550-6. PubMed ID: 17667927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]